Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KOTAI Biotechnologies, Inc.
Minoh, Osaka-fu, Japankotai-bio.com ↗
- Ownership
- Private
- Employees
- ~20
- Development stage
- Preclinical
01
Overview
KOTAI Biotechnologies specializes in AI-driven immuno-informatics platforms focused on antibody sequence/structure modeling, immune repertoire analytics, and antigen design. Their technology has been validated through international competitions and academic publications. They collaborate with major pharma companies like Shionogi on universal coronavirus vaccine projects supported by Japanese government initiatives such as SCARDA. The company was acquired by Sanyo Trading Co. in August 2023 but continues to operate actively within the group.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Antibody modeling and analysisImmune repertoire sequencing and informaticsAntigen design for vaccinesBioinformatics/single-cell analysis
- Industry
- Drug Discovery Services
02
Partnerships
Astellas Pharma (antibody structure modeling collaboration)Osaka University Institute for Protein ResearchShionogi & Co., Ltd./SCARDA/National Institute of Infectious Diseases – universal coronavirus vaccine project
Beyond the preview
Go deeper on KOTAI Biotechnologies, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KOTAI Biotechnologies, Inc..